OHRE Pharma drugs

In compliance with art L.5121-1-3 of French Public Health Code, please find hereunder the list of medicinal product for which OHRE Pharma is responsable for placing on the market :

For more information concerning our drugs, you can click to the following link: French medicinal product data base.

For Voriconazole, Bosentan and Bortézomib Risk Management, OHRE Pharma laboratory provide medical information brochure (validated by the French National  Medicines Agency) to patients and healthcare professionals:

For Bosentan OHRE Pharma:

For Voriconazole OHRE Pharma:

  • Patient brochure focusing on the most important information in order to guarantee voriconazole safe use
    • To see or download this booklet follow this link.
  • Healthcare professional brochure with questions /answers and chek-list.
    • To see and download the HCP brochure, click on this link.
    • To see and download the checklist, click on this link.

For Bortézomib OHRE Pharma:

  • A leaflet to provide important information of the drug reconstitution, the dosage and the infusion of BORTEZOMIB OHRE Pharma Download
  • DOSAGE DIAGRAMS of BORTEZOMIB OHRE Pharma powder for solution for injection subcutaneously and intravenously for the induction treatment of patients with multiple myeloma eligible for hematopoietic stem cell transplantationDownload
  • The risk of error during the RECONSTRUCTION OF BORTEZOMIB OHRE Pharma 3,5 mg powder for solution for injection FOR SUBCUTANEOUS OR INTRAVENOUS ADMINISTRATION – Download

Last update realized in July 2020.